---
permalink: /
title: ""
excerpt: ""
author_profile: true
redirect_from: 
  - /about/
  - /about.html
---

{% if site.google_scholar_stats_use_cdn %}
{% assign gsDataBaseUrl = "https://cdn.jsdelivr.net/gh/" | append: site.repository | append: "@" %}
{% else %}
{% assign gsDataBaseUrl = "https://raw.githubusercontent.com/" | append: site.repository | append: "/" %}
{% endif %}
{% assign url = gsDataBaseUrl | append: "google-scholar-stats/gs_data_shieldsio.json" %}

<span class="anchor" id="about-me"></span>

## About Me

I am a **computational cancer genomics and pharmacogenomics researcher** with 8+ years of research experience spanning microbiology, oncology, and precision medicine.

My work focuses on **multi-omics data integration (RNA-seq / WES / WGS)** and **drug response profiling** to identify biomarkers and mechanisms underlying therapeutic sensitivity and resistance in cancer, particularly **pediatric acute leukemia**.

I am currently transitioning fully into **computational and data-driven biomedical research**, with an emphasis on reproducible analysis pipelines and translational precision oncology.

---

<span class="anchor" id="research"></span>

## Research Interests

- Computational cancer genomics  
- Pharmacogenomics & drug response prediction  
- Multi-omics data integration (RNA-seq, WES/WGS, drug sensitivity)  
- Translational precision oncology  

---

<span class="anchor" id="projects"></span>

## Projects

- **RNA-seq Analysis Pipeline (End-to-End)**  
  Reproducible RNA-seq workflow including QC, alignment, quantification, differential expression, and visualization.  
  ðŸ”— [GitHub: 202507_RNA-seq-analysis-pipeline](https://github.com/guanglan1118/202507_RNA-seq-analysis-pipeline)

- **Multi-omics Drug Response Analysis (ongoing)**  
  Integration of gene expression, genomic alterations, and drug sensitivity data to identify predictive biomarkers.

*(More computational projects in progress â€” actively expanding GitHub portfolio.)*

---

<span class="anchor" id="publications"></span>

## Selected Publications

### Pediatric Acute Lymphoblastic Leukemia
- **Tong PYG**, **Lin G**, Li CK, et al.  
  *Pediatric Blood & Cancer*, 2025. PMID: 39878315  
  *Homoharringtonine in Relapsed/Refractory Pediatric T-Cell Acute Lymphoblastic Leukemia:  
  A Case Series and a Report on the Use of In Vitro Drug Profiling.*

- Zhang C, Chan KYY, Ng WH, **Lin G**, Leung KTL, et al.  
  *Haematologica*, 2024. PMID: 38572553

### Solid Tumor (Breast / Lung / Liver Cancer)
- Jiang YP, Liao WJ, Xin QL, Wang R, **Lin G**, Xu N, et al.  
  *Genes & Diseases*, 2025. DOI: 10.1016/j.gendis.2025.101684

- **Lin G**, Li J, Xu N, et al.  
  *Journal of Cancer*, 2021. PMID: 34659561  
  *RNA-binding protein MBNL2 regulates cancer cell metastasis through miR-182â€“MBNL2â€“AKT.*

---

<span class="anchor" id="skills"></span>

## Skills

- **Programming & Data**: R, Python, Linux, HPC  
- **Bioinformatics**: RNA-seq, WES/WGS, differential expression, drug response analysis  
- **Analysis**: Multi-omics integration, biomarker discovery, clinical-genomic association  
- **Experimental (background)**: PDX models, CRISPR, flow cytometry, drug screening  

---

<span class="anchor" id="educations"></span>

## Education

- **Ph.D. in Medical Sciences**  
  The Chinese University of Hong Kong  

- **M.Sc. in Precision Medicine and Healthcare**  
  Tsinghua Shenzhen International Graduate School, Tsinghua University  

- **B.Sc. in Biological Sciences**  
  Fujian Agriculture and Forestry University  

---

<span class="anchor" id="honors-and-awards"></span>

## Honors & Awards

- **ASH Abstract Achievement Award**, ASH Annual Meeting, 2023  
- Selected oral/poster presentations at international conferences

---

